AGM/EGMJul 22, 2026, 04:18 PM
Galmed Pharma to Hold AGM; Proposes Name Change to Eocene Ltd.
AI Summary
Galmed Pharmaceuticals Ltd. announced its Annual General Meeting of Shareholders to be held on August 26, 2026. Key agenda items include the re-election of two Class III directors, approval of an amendment to the Articles of Association to eliminate the par value of ordinary shares and change the company name to Eocene Ltd. Shareholders will also vote on a new Compensation Policy for Executive Officers and Directors, an amendment to increase directors' compensation by 20%, and the reappointment of the independent registered public accounting firm.
Key Highlights
- Annual General Meeting to be held on August 26, 2026, at 4:00 p.m. Israel time.
- Shareholders to vote on re-election of Dr. David Sidransky and Mr. Amir Poshinski as Class III directors.
- Proposal to amend Articles of Association to eliminate par value of Ordinary Shares.
- Proposal to change company name from Galmed Pharmaceuticals Ltd. to Eocene Ltd.
- Shareholders to approve new Compensation Policy for Executive Officers and Directors.
- Proposal to approve a 20% increase in directors' annual compensation.
- Reappointment of Brightman Almagor Zohar & Co. as independent registered public accounting firm for 2026.
Price Impact
More from GLMD